Table 1.
Clinicopathologic characteristics of the ovarian cancer patients.
| Clinicopathologic Parameters | n | Percentage (%) |
|---|---|---|
| Histology | ||
| Serous | 110 | 70.5 |
| Clear cell | 12 | 7.7 |
| Endometrioid | 21 | 13.5 |
| Mucinous | 13 | 8.3 |
| Primary tumor expansion | ||
| TX | 1 | 0.6 |
| T1 | 40 | 25.6 |
| T2 | 18 | 11.5 |
| T3 | 97 | 62.3 |
| Nodal status | ||
| pNX | 61 | 39.1 |
| pN0 | 43 | 27.6 |
| pN1 | 52 | 33.3 |
| Distant Metastasis | ||
| pMX | 147 | 94.2 |
| pM0 | 3 | 1.9 |
| pM1 | 6 | 3.8 |
| Grading Serous | ||
| Low | 24 | 21.8 |
| High | 80 | 72.7 |
| Grading Endometrioid | ||
| G1 | 6 | 28.6 |
| G2 | 5 | 23.8 |
| G3 | 8 | 38.1 |
| Grading Mucinous | ||
| G1 | 6 | 46.2 |
| G2 | 6 | 46.2 |
| G3 | 0 | 0 |
| Grading Clear cell | ||
| G3 | 12 | 100.0 |
| FIGO | ||
| I | 35 | 22.4 |
| II | 10 | 6.4 |
| III | 103 | 66.0 |
| IV | 3 | 1.9 |
| Residual disease after primary surgery | ||
| unknown | 143 | 91.7 |
| complete cytoreduction | 11 | 7.1 |
| incomplete cytoreduction | 2 | 1.3 |
| Age | ||
| ≤60 years | 83 | 53.2 |
| >60 years | 73 | 46.8 |